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account 184 (72.4%) and 153 (60.2%) of them were exposed for
bloodwhileunglovedandbodyﬂuid, respectively. Consistentuseof
gloveswas reported by52.4% of respondents. Of the total studypar-
ticipants, 9 (3.5%) of respondents were vaccinated against hepatitis
B virus infection.
Conclusion: The study declared that exposure for potentially
infectious body ﬂuids including blood, needle stick injuries, sharp
injury and other risk factors was high. But, the study indicated
only very small percentages of health professionals were partially
vaccinated for HBV. Taking into account the chance of potential
exposure, there is a need to focus efforts on mitigating blood borne
pathogen transmission through making the work place environ-
ment safe and making use of the available vaccine by vaccinating
all health care workers at the start of their career.
http://dx.doi.org/10.1016/j.ijid.2016.02.558
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Background: Drug resistant TB in China has been rapidly grow-
ing and becoming a cause for critical public health concern. It
was reported that the acquired drug-resistant TB mainly results
from incompliance to treatment, uncompleted treatment, irregular
treatment and unqualiﬁed health services.
Methods & Materials: Case-cohort was established in four
counties in eastern rural China. All registered active TB patients
from April 2013 to March 2014 were investigated using structure
questionnaire to collect demographic, geographic,socioeconomic
information and disease proﬁle. Enzyme-linked immunosorbent
assay (ELISA)wasused toassess the level of serumcytokines (IFN-,
IL - 4) before anti-TB treatment. All the participants were followed
up 6 or 8 months until treatment was completed.
Results: In total, 1404 patients were recruited, in which 1270
(94.5%)werenewlydiagnosedTBpatients, 447 (33.8%)were smear-
positive (SS+). The average agewas 49.5±18.8, and 76.2%wasmale.
The serum IFN- and IL-4 before anti-TB treatment was 7.936 and
12.292 pg/ml respectively. 80.9% of newly diagnosed TB patients
received standard anti-TB treatment, while 87.7% retreatment TB
patients received standard anti-TB treatment. The successfully
treated rate was 92.5% and 78.6% of new TB patients and retreat-
ment TB patients respectively. The sputum conversion rate of SS+
TB patients after 2 month anti-TB treatment was 96.5%, while the
cure rate and successful rate was 80.5% and 90.0% respectively.
92.6% smear-negative patients completed anti-TB treatment. The
successful rate in Jiangsu (97.3%), the more developed area, was
higher than in Jiangxi (87.6%) (OR = 6.276, 95% CI: 2.528 15.579).
Patientswith BMI<18.5may bemore risk to fail the treatment com-
pared with the health BMI (18.5-23.9) patients (OR = 3.196, 95% CI:
1.592 6.418). There was no relationship between serum cytokines
level and treatment outcomes. The cure rate of TB comorbiditywith
diabetes was same as the one without diabetes.
Conclusion: The sputumconversion rate, cure rate and success-
ful rate of TB patients were high in eastern rural China. Improving
patients’ nutrition, keeping a healthy BMI could be the key point of
increasing successfully treated rate of tuberculosis. More research
should be done in future to evaluate the impact of the serum
cytokines during anti-TB treatment.
http://dx.doi.org/10.1016/j.ijid.2016.02.559
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Background: Tenofovir disoproxil fumerate (TDF) is bioavail-
able prodrug of Tenofovir, a potent nucleotide reverse transcriptase
inhibitor.TDF causes Proximal tubular dysfunction and Fanconi’s
Syndrome. Number of patients on TDF in India is rising due to
decrease in cost and availability of TDF in both ﬁrst and second line
antiretroviral therapy (ART) regimen through National ART pro-
gramme.TDF related renal toxicity in our population has not been
studied systematically. Hence this study was undertaken.
Methods & Materials: This descriptive study was done on HIV
positive patients on stable cART containing TDF with normal Renal
function at baseline, attending ART centres under KMC Hospital,
Mangalore from September 2012 to Dec 2013. Data was collected
by semi structured proforma which included sociodemographic
proﬁle, duration of HIV and cART,CD4 count, body weight, BMI,
creatinine, GFR using Cockcroft-Gault equation. Using RIFLE Crite-
ria (Risk, Injury, Failure, Loss, End stage) by Acute Dialysis Quality
Initiative Group, patients were divided into different stages. Data
was analysed using SPSS Version 11.5.
Results: 63 patients who met inclusion criteria participated in
this study.35 were male and 28 female. Median duration on TDF
was 10 months(7-14months). 25(39.68%) developed renal failure
according to RIFLE Criteria.21(84%) out of these had Risk,2 had
Injury, 1 Failure and 1 Loss.22 patients out of 56 (36%) on NNRTI
based regimen and 3 out of 7(43%) patients on Protease Inhibitor
based regimen had Renal Toxicity.15 (60%) of patients with renal
toxicity had weight less than 53kg (p=0.001).16(64%) had CD4
Count less than 275 cells/ml (p=0.02).12 out of 28 females (42%)
and 13 out of 35 males (37%)(p=0.01) had renal toxicity.
Conclusion: TDF induced renal toxicity is high, though major-
ity of patients had mild toxicity. Low body weight, female sex,Low
CD4 Counts and Protease Inhibitor based cART are risk factors for
renal toxicity. Frequent monitoring of renal functions is advocated
among patients with these risk factors who are started on TDF.
http://dx.doi.org/10.1016/j.ijid.2016.02.560
